ATE469917T2 - Verfahren zur gewinnung von antikörpern - Google Patents
Verfahren zur gewinnung von antikörpern Download PDFInfo
- Publication number
- ATE469917T2 ATE469917T2 AT05803527T AT05803527T ATE469917T2 AT E469917 T2 ATE469917 T2 AT E469917T2 AT 05803527 T AT05803527 T AT 05803527T AT 05803527 T AT05803527 T AT 05803527T AT E469917 T2 ATE469917 T2 AT E469917T2
- Authority
- AT
- Austria
- Prior art keywords
- relates
- obtaining antibodies
- yield
- subjected
- manufacture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0425534.5A GB0425534D0 (en) | 2004-11-19 | 2004-11-19 | Process for obtaining antibodies |
PCT/GB2005/004397 WO2006054063A1 (en) | 2004-11-19 | 2005-11-16 | Process for obtaining antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE469917T2 true ATE469917T2 (de) | 2010-06-15 |
Family
ID=33548568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05803527T ATE469917T2 (de) | 2004-11-19 | 2005-11-16 | Verfahren zur gewinnung von antikörpern |
Country Status (11)
Country | Link |
---|---|
US (1) | US8969036B2 (de) |
EP (1) | EP1814912B2 (de) |
JP (1) | JP4843616B2 (de) |
CN (1) | CN101065402B (de) |
AT (1) | ATE469917T2 (de) |
AU (1) | AU2005305681B2 (de) |
CA (1) | CA2584226C (de) |
DE (1) | DE602005021678D1 (de) |
ES (1) | ES2346673T5 (de) |
GB (1) | GB0425534D0 (de) |
WO (1) | WO2006054063A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0425537D0 (en) * | 2004-11-19 | 2004-12-22 | Celltech R&D Ltd | Process for obtaining antibodies |
KR101643514B1 (ko) | 2007-07-09 | 2016-07-27 | 제넨테크, 인크. | 폴리펩티드의 재조합 생산 동안의 디술피드 결합 환원의 방지 |
CA2701338C (en) * | 2007-10-15 | 2018-09-18 | Chugai Seiyaku Kabushiki Kaisha | Method for production of antibody |
US9109216B2 (en) | 2009-09-24 | 2015-08-18 | Ucb Pharma, S.A. | Bacterial host strain |
GB201000590D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
GB201000591D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
GB201000587D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
GB201001791D0 (en) * | 2010-02-03 | 2010-03-24 | Ucb Pharma Sa | Process for obtaining antibodies |
GB201012599D0 (en) | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Process for purifying proteins |
HUE035674T2 (en) | 2011-07-13 | 2018-05-28 | Ucb Biopharma Sprl | Bacterial host strains expressing recombinant DSBC |
GB201208367D0 (en) | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Biological product |
CN102757496B (zh) * | 2012-06-07 | 2014-06-18 | 山东泉港药业有限公司 | 一种抗vegf抗体片段的纯化制备方法 |
WO2016102383A1 (en) * | 2014-12-22 | 2016-06-30 | Ucb Biopharma Sprl | Protein manufacture |
BR112017013398B1 (pt) | 2014-12-22 | 2023-12-05 | Ucb Biopharma Sprl | Método de fabricar anticorpo ou fragmento de ligação ao antígeno do mesmo |
GB201506869D0 (en) * | 2015-04-22 | 2015-06-03 | Ucb Biopharma Sprl | Method |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5328989B2 (de) * | 1974-05-27 | 1978-08-17 | ||
WO1991001367A1 (en) * | 1989-07-20 | 1991-02-07 | Bioeng, Inc. | Supercritical fluid disruption of and extraction from microbial cells |
US7018809B1 (en) | 1991-09-19 | 2006-03-28 | Genentech, Inc. | Expression of functional antibody fragments |
GB9215540D0 (en) * | 1992-07-22 | 1992-09-02 | Celltech Ltd | Protein expression system |
US6455287B1 (en) * | 1995-02-23 | 2002-09-24 | Wyeth | Mechanical disruption of bacterial cells for plasmid recovery |
DE19513676A1 (de) * | 1995-04-11 | 1996-10-17 | Behringwerke Ag | Cytoplasmatische Expression von Antikörpern, Antikörperfragmenten und Antikörperfragmentfusionsmolekülen in E.coli |
US6120985A (en) * | 1997-10-31 | 2000-09-19 | Bbi Bioseq, Inc. | Pressure-enhanced extraction and purification |
GB0319601D0 (en) * | 2003-08-20 | 2003-09-24 | Sandoz Ag | Production process |
-
2004
- 2004-11-19 GB GBGB0425534.5A patent/GB0425534D0/en not_active Ceased
-
2005
- 2005-11-16 US US11/791,107 patent/US8969036B2/en active Active
- 2005-11-16 WO PCT/GB2005/004397 patent/WO2006054063A1/en active Application Filing
- 2005-11-16 AU AU2005305681A patent/AU2005305681B2/en active Active
- 2005-11-16 CA CA2584226A patent/CA2584226C/en active Active
- 2005-11-16 ES ES05803527.0T patent/ES2346673T5/es active Active
- 2005-11-16 CN CN2005800395236A patent/CN101065402B/zh active Active
- 2005-11-16 JP JP2007542089A patent/JP4843616B2/ja active Active
- 2005-11-16 AT AT05803527T patent/ATE469917T2/de active
- 2005-11-16 DE DE602005021678T patent/DE602005021678D1/de active Active
- 2005-11-16 EP EP05803527.0A patent/EP1814912B2/de active Active
Also Published As
Publication number | Publication date |
---|---|
JP2008520225A (ja) | 2008-06-19 |
CA2584226A1 (en) | 2006-05-26 |
DE602005021678D1 (de) | 2010-07-15 |
EP1814912B2 (de) | 2017-10-25 |
AU2005305681A1 (en) | 2006-05-26 |
ES2346673T5 (es) | 2018-02-15 |
WO2006054063A1 (en) | 2006-05-26 |
EP1814912A1 (de) | 2007-08-08 |
CA2584226C (en) | 2015-09-15 |
GB0425534D0 (en) | 2004-12-22 |
CN101065402B (zh) | 2011-07-20 |
US20080003644A1 (en) | 2008-01-03 |
EP1814912B1 (de) | 2010-06-02 |
JP4843616B2 (ja) | 2011-12-21 |
CN101065402A (zh) | 2007-10-31 |
ES2346673T3 (es) | 2010-10-19 |
AU2005305681B2 (en) | 2011-04-21 |
US8969036B2 (en) | 2015-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE469917T2 (de) | Verfahren zur gewinnung von antikörpern | |
EA200970263A1 (ru) | Полностью человеческая высокопродуктивная система получения усовершенствованных антител и белков | |
ATE481483T1 (de) | Verfahren zur herstellung eines rekombinanten polyklonalen proteins | |
WO2006041934A3 (en) | Methods and compositions for improving recombinant protein production | |
EA200700917A1 (ru) | Способ рефолдинга рекомбинантных антител | |
NZ627668A (en) | Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography | |
DE602004025805D1 (de) | Verfahren zur herstellung von antikörpern | |
WO2004065417A3 (en) | Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture | |
DE602005021379D1 (de) | System und verfahren zur produktion von antikörpern in der pflanzenzellkultur | |
TW200638944A (en) | Recombinant enterovirus 71 neutralizing antibodies and use thereof | |
DE602006021324D1 (de) | Verfahren zur herstellung stabiler b-lymphozyten | |
DE602005025878D1 (de) | Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung | |
DE602006018054D1 (de) | Translationselongationsfaktor-promotor aus pichia pastoris und verfahren zur herstellung von rekombinantem protein unter verwendung davon | |
BR112012012911A8 (pt) | métodos para triar uma molécula capaz de ligação a cd4, para produzir uma composição terapêutica, para triar um anticorpo ou fragmento de anticorpo capaz de ligar cd4, para a produção de um anticorpo ou fragmento de anticorpo in vitro para a ativação de células t regulatórias cd4+cd25+, para tratar um indivíduo, e para triar a presença de células regulatórias t cd4+cd25+ em uma amostra, composição terapêutica, anticorpo ou fragmento de anticorpo, peptídeo isolado, mimótopo de um peptídeo isolado, ácido nucleico, vetor, célula hospedeira ou hibridoma, usos de um anticorpo ou fragmento de anticorpo, do peptídeo isolado e de uma célula t regulatória cd4+cd25+, célula t regulatória cd4+cd25+, e, kit. | |
WO2003064622A3 (en) | Aggrecanase molecules | |
WO2010002966A3 (en) | High throughput screening method and use thereof to identify a production platform for a multifunctional binding protein | |
DE602005026099D1 (de) | Transformierte saccharomyces cerevisiae sowie verfahren zur massenproduktion des proteins lk8 damit | |
DE60214127D1 (de) | Hybridomzelllinie g250 und deren verwendung zur herstellung monoklonaler antikörper | |
DE602004029578D1 (de) | Verfahren zur immuntherapie von tumoren | |
ATE373824T1 (de) | Verfahren zur qualitativen und/oder quantitativen bestimmung von gattung, art, rasse und/oder geographischer herkunft biologischer materialien | |
DE50307968D1 (de) | Antikörper zur isolierung und/oder identifizierung mesenchymaler stammzellen und verfahren zur isolierung und/oder identifizierung mesenchymaler stammzellen | |
EA200702009A1 (ru) | Усовершенствованный способ экспрессирующего клонирования в клетке-хозяине | |
EP1916298A4 (de) | Antikörperherstellungsverfahren | |
ATE521637T1 (de) | Verfahren zur herstellung loeslicher mhc-proteine | |
ATE381576T1 (de) | Verfahren zur aufreinigung eines n-terminalen fragments des hepatozytenwachstumsfaktors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1814912 Country of ref document: EP |